HMGA2 and cancer: The hitherto unknown ability of HMGA2 to regulate nuclear CDC25C content independent of pCDC25CS216 status requires further investigations and may be clinically relevant as low cellular HMGA2 levels promote the emergence of cancer cell populations with heterogeneous telomere phenotypes.